Ryan Brown

ORCID: 0000-0002-7650-9685
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cancer Immunotherapy and Biomarkers
  • Immunotherapy and Immune Responses
  • Advanced Radiotherapy Techniques
  • Radiopharmaceutical Chemistry and Applications
  • Congenital heart defects research
  • Immune Cell Function and Interaction
  • Prostate Cancer Diagnosis and Treatment
  • Cancer Research and Treatments
  • interferon and immune responses
  • Radiation Dose and Imaging
  • Nanoplatforms for cancer theranostics
  • Cardiomyopathy and Myosin Studies
  • Advanced Breast Cancer Therapies
  • CAR-T cell therapy research
  • Immune cells in cancer
  • Cancer, Hypoxia, and Metabolism
  • Mathematical Biology Tumor Growth
  • Photodynamic Therapy Research Studies
  • Brain Metastases and Treatment
  • Ultrasound and Hyperthermia Applications
  • Cancer Mechanisms and Therapy
  • Biosimilars and Bioanalytical Methods
  • Chromatin Remodeling and Cancer
  • IL-33, ST2, and ILC Pathways
  • Drug Transport and Resistance Mechanisms

Northwestern University
2023-2025

University of Glasgow
2025

Medical College of Wisconsin
2020-2024

University of Wisconsin–Madison
2018-2021

St George Hospital
2018-2021

Cardiff Metropolitan University
2018

Amgen (United States)
2012-2016

Neoantigens induced by random mutations and specific to an individual's cancer are the most important tumor antigens recognized T cells. Among immunologically "cold" tumors, limited recognition of neoantigens results in absence a de novo antitumor immune response. These tumors present clinical challenge as they poorly responsive immunotherapies, including checkpoint inhibitors (ICIs). Radiation therapy (RT) can enhance resulting more diversified T-cell response, yet RT alone rarely systemic...

10.1002/adma.201902626 article EN publisher-specific-oa Advanced Materials 2019-09-16

Abstract Finding improved therapeutic strategies against T-cell Non-Hodgkin’s Lymphoma (NHL) remains an unmet clinical need. We implemented a theranostic approach employing tumor-targeting alkylphosphocholine (NM600) radiolabeled with 86 Y for positron emission tomography (PET) imaging and 90 targeted radionuclide therapy (TRT) of NHL. PET biodistribution performed in mouse models NHL showed vivo selective tumor uptake retention Y-NM600. An initial toxicity assessment examining complete...

10.1038/s42003-019-0327-4 article EN cc-by Communications Biology 2019-02-26

Clinical interest in combining targeted radionuclide therapies (TRT) with immunotherapies is growing. External beam radiation therapy (EBRT) activates a type 1 interferon (IFN1) response mediated via stimulator of genes (STING), and this critical to its therapeutic interaction immune checkpoint blockade. However, little known about the time course IFN1 activation after EBRT or whether may be induced by decay TRT source.

10.7150/thno.54881 article EN cc-by Theranostics 2021-01-01

Abstract Influenza virus infection causes increased morbidity and mortality in the elderly. Aging impairs immune response to influenza, both intrinsically because of altered interactions with endothelial pulmonary epithelial cells. To characterize these changes, we performed single-cell RNA sequencing (scRNA-seq), spatial transcriptomics, bulk (bulk RNA-seq) on lung tissue from young aged female mice at days 0, 3, 9 post-influenza infection. Our analyses identified dozens key genes...

10.1038/s41467-023-42021-y article EN cc-by Nature Communications 2023-10-18

Due to the complex molecular structure and proprietary manufacturing processes of monoclonal antibodies (mAbs), differences in function may be expected during development biosimilar mAbs. Important regulatory requirements for approval products involve comprehensive assessments any potential between proposed biosimilars reference mAbs, including all known mechanisms action, using sensitive relevant methods. Any identified structural should not result biofunctional or clinical activity. A...

10.1007/s40259-016-0185-2 article EN cc-by-nc BioDrugs 2016-07-15

During chronic viral infection and cancer, it has been established that a subset of progenitor CD8+ T cells continuously gives rise to terminally exhausted cytotoxic effector cells. Although multiple transcriptional programs governing the bifurcated differentiation trajectories have previously studied, little is known about chromatin structure changes regulating cell-fate decision. In this study, we demonstrate remodeling complex PBAF restrains expansion promotes exhaustion during cancer....

10.1016/j.celrep.2023.112649 article EN cc-by Cell Reports 2023-06-01

We report two synthetic strategies for the preparation of dibenzofuran α-amino acids, expanding structural toolbox fluorescent probes. The involved synthesis via a Pd(II)-catalyzed C–O cyclization, alongside an efficient Negishi coupling approach faster access to analogues. These rigid tyrosine mimics possess enhanced properties compared proteinogenic amino acids as demonstrated by application lead compound FRET donor monitoring peptide hydrolysis serine protease.

10.1021/acs.orglett.5c00433 article EN cc-by Organic Letters 2025-03-02

Effective co-stimulation of CD8 T cells is critical for maintenance TCF-1+ stem-like necessary long-term tumor control. NKG2D via binding stress ligands such as membrane-bound MIC enhances cell effector functions and important promoting memory development. Cancer often shed into a soluble form (sMIC) that inhibits activation. TRAMP prostate mice expressing human MICB (TRAMP/MICB) treated with anti-sMIC/MIC antibody elicited potent anti-tumor responses re-invigorated immunity. However,...

10.1158/1538-7445.am2025-4858 article EN Cancer Research 2025-04-21

Abstract Purpose The aim of this project was to design and manufacture a cost‐effective end‐to‐end (E2E) phantom for quantifying the geometric dosimetric accuracy linear accelerator based, multi‐target single‐isocenter ( MTSI ) frameless stereotactic radiosurgery SRS technique. Method A perspex Multi‐Plug device from Sun Nuclear ArcCheck (Sun Nuclear, Melbourne, FL) enhanced make it more applicable E2E testing. following steps in chain were then analysed using phantom: magnetic resonance...

10.1002/acm2.12452 article EN cc-by Journal of Applied Clinical Medical Physics 2018-09-16

β-Secretase inhibitors are potentially disease-modifying treatments for Alzheimer's disease. Previous efforts in our laboratory have resulted hydroxyethylamine-derived such as 1 with low nanomolar potency against β-site amyloid precursor protein cleaving enzyme (BACE). When dosed intravenously, compound was also shown to significantly reduce Aβ40 levels plasma, brain, and cerebral spinal fluid. Herein, we report further optimizations that led the discovery of inhibitor 16 a novel, potent,...

10.1021/ml3000148 article EN ACS Medicinal Chemistry Letters 2012-03-29

Introduction Combining CpG oligodeoxynucleotides with anti-OX40 agonist antibody (CpG+OX40) is able to generate an effective in situ vaccine some tumor models, including the A20 lymphoma model. Immunologically “cold” tumors, which are typically less responsive immunotherapy, characterized by few infiltrating lymphocytes (TILs), low mutation burden, and limited neoantigen expression. Radiation therapy (RT) can change microenvironment (TME) of immunologically tumor. This study investigated...

10.3389/fimmu.2021.763888 article EN cc-by Frontiers in Immunology 2021-11-15

Abstract During chronic viral infection, CD4+ T cells help in the form of IL-21 is critical for development highly cytolytic effector CD8+ cells. However, exact signaling pathways from that regulate cell function remain unclear. The current dogma states predominantly signals through STAT3, to generate during infection. Here, we reveal a novel mechanism via STAT4 following LCMV Furthermore, STAT4-mediated differentiation epigenetically regulated by BAF, SWI/SNF chromatin remodeling complex....

10.4049/jimmunol.212.supp.1265.5810 article EN The Journal of Immunology 2024-05-01

Abstract T cell exhaustion, a state of dysfunction occurring during chronic infections and cancer, is marked by progressive loss effector functions increased expression inhibitory receptors. In infection, CD8 cells differentiate into TCF1+ progenitor (TPRO), CX3CR1+ (TEFF), terminally exhausted (TEXH) subsets. The differentiation pathways are governed complex transcription factor (TF) networks. Employing regulon analysis enabled single-cell RNA+ATAC multiome sequencing, we dissected the TF...

10.4049/jimmunol.212.supp.0217.4786 article EN The Journal of Immunology 2024-05-01

Abstract Repetitive T cell receptor (TCR) engagement on CD8 cells during chronic infection is a critical driver of the dysfunctional state termed exhaustion. These exhausted are characterized by additional heterogeneity including memory-like progenitor (Tpro) that continuously gives rise to either non-cytolytic (Texh) or cytotoxic effector (Teff). While we and others have shown TCR avidity influence fate commitment Texh Teff, it not certain if sequence features this choice. In study,...

10.4049/jimmunol.212.supp.1475.4805 article EN The Journal of Immunology 2024-05-01

We demonstrate here that iPSCs derived from patients with Ebstein’s anomaly and left ventricular noncompaction, when differentiated into cardiomyocytes, display significant structural functional changes offer insight disease pathogenesis, including altered ER/SR mitochondrial morphology, contractility, calcium signaling.

10.1152/ajpheart.00658.2022 article EN AJP Heart and Circulatory Physiology 2023-05-19

Hypoplastic left heart syndrome (HLHS) is a complex form of congenital disease (CHD) characterized by hypoplasia the ventricle and proximal aorta, as well stenosis or atresia mitral aortic valves. Our lab previously identified that rare, predicted-damaging variants in gene encoding for α-myosin heavy chain ( MYH6, α-MHC), key contractile protein heart, are enriched HLHS. It has been shown pathological MHC head domain directly alter force generation, but mechanisms which tail cause defects...

10.1152/physiol.2023.38.s1.5733555 article EN Physiology 2023-05-01

Surgical resection or hypo-fractionated radiation therapy (RT) in early-stage non-small cell lung cancer (NSCLC) achieves local tumor control, but metastatic relapse remains a challenge. We hypothesized that immunotherapy with anti-CTLA-4 and bempegaldesleukin (BEMPEG; NKTR-214), CD122-preferential IL2 pathway agonist, after primary RT would reduce metastases syngeneic murine NSCLC model. Mice bearing Lewis Lung Carcinoma (LLC) tumors were treated combinations of BEMPEG, anti-CTLA-4,...

10.3389/fonc.2021.645352 article EN cc-by Frontiers in Oncology 2021-04-15
Coming Soon ...